Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596424 | PMC |
| http://dx.doi.org/10.1038/cdd.2017.122 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 Pandemic.
J Clin Med
January 2025
Department of Life Sciences and Biotechnology, Ferrara University, 44121 Ferrara, Italy.
: Cellular biobanks are of great interest for performing studies finalized in the development of personalized approaches for genetic diseases, including β-thalassemia and sickle cell disease (SCD), important diseases affecting the hematopoietic system. These inherited genetic diseases are characterized by a global distribution and the need for intensive health care. The aim of this report is to present an update on the composition of a cellular Thal-Biobank, to describe its utilization since 2016, to present data on its application in studies on fetal hemoglobin induction and on gene editing, and to discuss its employment as a "unique tool" during and after the COVID-19 pandemic.
View Article and Find Full Text PDFCure the Incurable: Update of Treatment in Inherited Neuromuscular Disorders.
Acta Neurol Taiwan
December 2024
Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan; College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Brain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Originally thought to be incurable, huge therapeutic progress has been made in recent years in the field of inherited neuromuscular disorders. Approaches aiming to rescue the underlying pathophysiology, i.e.
View Article and Find Full Text PDFArticle Synopsis
- Cancer rates are rising globally, necessitating more effective and low-toxicity treatment options, which can be achieved through nanotechnology tailored to individual patients' tumors.
- Nanomedicine is making strides with various nanoformulations in clinical trials and some already on the market, but there are hurdles to widespread use, including ethical, safety, and cost concerns.
- The text highlights advances in personalized diagnostics and therapies through technologies like organ-on-chip and CRISPR/Cas9, while also addressing the future prospects and challenges of integrating nano-based precision oncology into everyday clinical practice.
Exploiting L. subsp. Genome Research.
Plants (Basel)
October 2024
Shandong Key Laboratory of Bulk Open-field Vegetable Breeding, Ministry of Agriculture and Rural Affairs Key Laboratory of Huang Huai Protected Horticulture Engineering, Institute of Vegetables, Shandong Academy of Agricultural Sciences, Jinan 250100, China.
Chinese cabbage, L. subsp. is a crucial and extensively consumed vegetable in the world, especially Eastern Asia.
View Article and Find Full Text PDFCurrent Updates of CRISPR/Cas System and Anti-CRISPR Proteins: Innovative Applications to Improve the Genome Editing Strategies.
Int J Nanomedicine
October 2024
Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia.
Article Synopsis
- The CRISPR/Cas system is a powerful genome-editing tool used in biomedical research to manipulate genes associated with both normal and disease functions, known for its efficiency and specificity.
- Key challenges in its therapeutic applications include safe delivery to target cells and minimizing off-target effects, which can be addressed by understanding anti-CRISPR proteins (Acrs) that can inhibit the CRISPR/Cas system.
- Acrs operate through various mechanisms, and recent research on their action can enhance the safe use of CRISPR/Cas technologies, potentially leading to advancements in gene therapy, diagnostics, and antimicrobial treatments.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!